Does peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduce the size of experimental endometriosis in the rat model?
Rosiglitazone was found to cause regression of experimental endometriosis in rats.
Oxidative stress and inflammation may be key factors in the development of bladder overactivity in atherosclerosis-induced chronic bladder ischemia.